Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3679048, 6 pages
http://dx.doi.org/10.1155/2016/3679048
Research Article

The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions

Department of Pharmacology and Therapeutics, Collegium Medicum Nicolaus Copernicus University, Sklodowskiej-Curie Street 9, 85-094 Bydgoszcz, Poland

Received 19 May 2016; Revised 4 July 2016; Accepted 10 July 2016

Academic Editor: Gjumrakch Aliev

Copyright © 2016 Katarzyna Szadujkis-Szadurska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Palombo, G. L. Blackburn, and R. A. Forse, “Endothelial cell factors and response to injury,” Surgery Gynecology & Obstetrics, vol. 173, no. 6, pp. 505–518, 1991. View at Google Scholar · View at Scopus
  2. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 327, no. 6122, pp. 524–526, 1987. View at Publisher · View at Google Scholar · View at Scopus
  3. H. K. Diep, E. J. Vigmond, S. S. Segal, and D. G. Welsh, “Defining electrical communication in skeletal muscle resistance arteries: a computational approach,” Journal of Physiology, vol. 568, no. 1, pp. 267–281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. E. L. Rowe and N. A. White, “Reperfusion injury in the equine intestine,” Clinical Techniques in Equine Practice, vol. 1, no. 3, pp. 148–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Tribe, M. L. Borin, and M. P. Blaustein, “Functionally and spatially distinct Ca2+ stores are revealed in cultured vascular smooth muscle cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 5908–5912, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Kamm and J. T. Stull, “Dedicated myosin light chain kinases with diverse cellular functions,” Journal of Biological Chemistry, vol. 276, no. 7, pp. 4527–4530, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. Moore, W. W. Muir, and D. N. Granger, “Mechanisms of gastrointestinal ischemia-reperfusion injury and potential therapeutic interventions: a review and its implications in the horse,” Journal of Veterinary Internal Medicine, vol. 9, no. 3, pp. 115–132, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Slupski, L. Szadujkis-Szadurski, G. Grześk et al., “Guanylate cyclase activators influence reactivity of human mesenteric superior arteries retrieved and preserved in the same conditions as transplanted kidneys,” Transplantation Proceedings, vol. 39, no. 5, pp. 1350–1353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Szadujkis-Szadurska, G. Grzesk, L. Szadujkis-Szadurski, M. Gajdus, and G. Matusiak, “Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion,” Experimental and Therapeutic Medicine, vol. 5, no. 2, pp. 616–620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. M. Moore, J. Hardy, and W. W. Muir, “Mural blood flow distribution in the large colon of horses during low-flow ischemia and reperfusion,” American Journal of Veterinary Research, vol. 56, no. 6, pp. 812–818, 1995. View at Google Scholar · View at Scopus
  11. D. N. Granger, J. N. Benoit, M. Suzuki, and M. B. Grisham, “Leukocyte adherence to venular endothelium during ischemia-reperfusion,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 257, no. 5, pp. G683–G688, 1989. View at Google Scholar · View at Scopus
  12. K. Szadujkis-Szadurska, G. Grzesk, L. Szadujkis-Szadurski, M. Gajdus, B. Malinowski, and M. Wicinski, “Role of endothelium, acetylocholine and calcium ions in Bay K8644- and KCl-induced contraction,” Molecular Medicine Reports, vol. 8, no. 3, pp. 914–918, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Oliver and E. A. Schäfer, “On the physiological action of extracts of pituitary body and certain other glandular organs,” The Journal of Physiology, vol. 18, no. 3, pp. 277–279, 1895. View at Publisher · View at Google Scholar
  14. P. R. Kalra, S. D. Anker, and A. J. S. Coats, “Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin,” Cardiovascular Research, vol. 51, no. 3, pp. 495–509, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Krejci, L. B. Hiltebrand, S. M. Jakob, J. Takala, and G. H. Sigurdsson, “Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow,” Critical Care, vol. 11, no. 6, article R129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Popp, P. Vogel, P. Teschendorf, and B. W. Böttiger, “Vasopressors are essential during cardiopulmonary resuscitation in rats: is vasopressin superior to adrenaline?” Resuscitation, vol. 72, no. 1, pp. 137–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Hauser, P. Asfar, E. Calzia, R. Laporte, M. Georgieff, and P. Radermacher, “Vasopressin in vasodilatory shock: is the heart in danger?” Critical Care, vol. 12, no. 2, article 132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Müller, O.-J. How, S. E. Hermansen, T. A. Stenberg, G. Sager, and T. Myrmel, “Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia,” Critical Care, vol. 12, no. 1, article R20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. P. M. Park, S. S. Gao, S. A. Cha, B. H. Park, and S. H. Kim, “Cardioprotective effects of angiotensin III against ischemic injury via the AT2 receptor and KATP channels,” Physiological Reports, vol. 1, no. 6, Article ID e00151, 2013. View at Publisher · View at Google Scholar
  20. A. Manaenko, N. Fathali, N. H. Khatibi et al., “Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury,” Neurochemistry International, vol. 58, no. 4, pp. 542–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-L. Yang, Z.-L. Shen, Q. Zou, Y. Tang, and T. Huang, “Physostigmine-induced hypothermic response in rats and its relationship with endogenous arginine vasopressin,” Life Sciences, vol. 85, no. 15-16, pp. 586–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. M. Briley, S. J. Lolait, J. Axelrod, and C. C. Felder, “The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels,” Neuropeptides, vol. 27, no. 1, pp. 63–74, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Szmydynger-Chodobska, B. J. Zink, and A. Chodobski, “Multiple sites of vasopressin synthesis in the injured brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 1, pp. 47–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. L. Holmes, D. W. Landry, and J. T. Granton, “Science review: vasopressin and the cardiovascular system part 1—receptor physiology,” Critical Care, vol. 7, no. 6, pp. 427–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. van Rossum, “Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters,” Archives Internationales de Pharmacodynamie et de Thérapie, vol. 143, pp. 299–330, 1963. View at Google Scholar · View at Scopus
  26. G. Grześk and L. Szadujkis-Szadurski, “Pharmacometric analysis of α1-adrenoceptor function in rat tail artery pretreated with lipopolysaccharides,” Polish Journal of Pharmacology, vol. 53, no. 6, pp. 605–613, 2001. View at Google Scholar · View at Scopus
  27. G. Grzesk and L. Szadujkis-Szadurski, “Physiological antagonism of angiotensin II and lipopolysaccharides in early endotoxemia: pharmacometric analysis,” Polish Journal of Pharmacology, vol. 55, pp. 753–762, 2003. View at Google Scholar
  28. A. Szabo and U. Heemann, “Ischemia reperfusion injury and chronic allograft rejection,” Transplantation Proceedings, vol. 30, no. 8, pp. 4281–4284, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. C. S. H. Ng, S. Wan, and A. P. C. Yim, “Pulmonary ischaemia-reperfusion injury: role of apoptosis,” European Respiratory Journal, vol. 25, no. 2, pp. 356–363, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Hashimoto, P. J. Pearson, H. V. Schaff, and R. Cartier, “Endothelial cell dysfunction after ischemic arrest and reperfusion: a possible mechanism of myocardial injury during reflow,” Journal of Thoracic and Cardiovascular Surgery, vol. 102, no. 5, pp. 688–694, 1991. View at Google Scholar · View at Scopus
  31. R. J. Dignan, C. M. Dyke, A. S. Abd-Elfattah et al., “Coronary artery endothelial cell and smooth muscle dysfunction after global myocardial ischemia,” The Annals of Thoracic Surgery, vol. 53, no. 2, pp. 311–317, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. J. Pittman and M. F. Wilkinson, “Central arginine vasopressin and endogenous antipyresis,” Canadian Journal of Physiology and Pharmacology, vol. 70, no. 5, pp. 786–790, 1992. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Richmond, “The role of arginine vasopressin in thermoregulation during fever,” The Journal of Neuroscience Nursing, vol. 35, no. 5, pp. 281–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. T. J. Martikainen, J. Kurola, V. Kärjä, I. Parviainen, and E. Ruokonen, “Vasopressor agents after experimental brain death: effects of dopamine and vasopressin on vitality of the small gut,” Transplantation Proceedings, vol. 42, no. 7, pp. 2449–2456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. D. Rosendale, H. M. Kauffman, M. A. McBride et al., “Aggressive pharmacologic donor management results in more transplanted organs,” Transplantation, vol. 75, no. 4, pp. 482–487, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Grześk, M. Wiciński, B. Malinowski et al., “Calcium blockers inhibit cyclosporine A-induced hyperreactivity of vascular smooth muscle cells,” Molecular Medicine Reports, vol. 5, no. 6, pp. 1469–1474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Grzesk, B. Malinowski, E. Grzesk et al., “Direct regulation of vascular smooth muscle contraction by mastoparan-7,” Biomedical Reports, vol. 2, pp. 34–38, 2014. View at Google Scholar
  38. L. G. Hall, L. J. Oyen, C. B. Taner et al., “Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock,” Pharmacotherapy, vol. 24, no. 8, pp. 1002–1012, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Szadujkis-Szadurska, G. Grzesk, L. Szadujkis-Szadurski, M. Gajdus, and G. Matusiak, “Role of acetylcholine and calcium ions in three vascular contraction models: angiotensin II, phenylephrine and caffeine,” Experimental and Therapeutic Medicine, vol. 4, no. 2, pp. 329–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Yetik-Anacak and J. D. Catravas, “Nitric oxide and the endothelium: history and impact on cardiovascular disease,” Vascular Pharmacology, vol. 45, no. 5, pp. 268–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Xu and L. Liu, “The role of calcium desensitization in vascular hyporeactivity and its regulation after hemorrhagic shock in the rat,” Shock, vol. 23, no. 6, pp. 576–581, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. R. F. Furchgott and J. V. Zawadzki, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980. View at Publisher · View at Google Scholar · View at Scopus